Last reviewed · How we verify

NCT06796985

Botox for Chronic Pelvic Pain

Recruiting now Phase 1 Last updated 29 July 2025
What this trial tests

Phase 1 trial testing Botulinum neurotoxin in Pelvic Floor Disorders in 30 participants. Currently enrolling.

Timeline
24 February 2025
Primary endpoint
22 March 2027
22 March 2027

Quick facts

Lead sponsorUniversity of Miami
PhasePhase 1
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposetreatment
Enrollment30
Start date24 February 2025
Primary completion22 March 2027
Estimated completion22 March 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Miami

Who can join

Adults 18 to 75, female only, with Pelvic Floor Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research study is to find out if precise, targeted injection of botulinum neurotoxin (commonly known as Botox) provides better relief of pelvic floor hypertonicity and pain than the standard method being used. The researchers want to better understand the effects (good and bad) of targeted botulinum neurotoxin injections in women with pelvic floor disorders.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pelvic Floor Disorders

Currently open trials in the same condition.

Other University of Miami trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06796985.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing